Close Menu

NEW YORK – T2 Biosystems today announced it entered into exclusive agreements with five new distribution partners in the first half of 2019, enabling it to introduce its rapid diagnostic tests in Estonia, Greece, Ireland, Saudi Arabia, and South Africa. These countries have about 1,170 hospitals that could benefit from its products, the firm said.

Financial and other terms of the agreement were not disclosed. T2 Bio also did not disclose the names of the distribution partners.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.